Skip to main content

Table 2 DVH analysis of planned dose and re-calculated dose for PTV

From: Total marrow lymphoid irradiation IMRT treatment using a novel CT-linac

PTV

Dmean (Gy)

Dmax (Gy)

D95 (Gy)

D90 (Gy)

V7 (%)

V8 (%)

V9 (%)

V10 (%)

V11 (%)

V12 (%)

PTVbone (10 Gy)

Plan

11.31 \(\pm\) 0.30

14.75 \(\pm\) 0.58

9.98 \(\pm\) 0.21

10.36

\(\pm\) 0.17

99.57

\(\pm\) 0.23

99.23

\(\pm\) 0.26

98.39

\(\pm\) 0.62

94.79

\(\pm\) 1.59

65.85

\(\pm\) 10.39

20.86

\(\pm\) 13.31

re-calculated

11.18 \(\pm\) 0.27

14.96 \(\pm\) 0.76

9.55 \(\pm\) 0.23

10.20

\(\pm\) 0.14

98.53

\(\pm\) 0.50

97.87

\(\pm\) 0.53

96.55

\(\pm\) 0.64

92.17

\(\pm\) 1.35

64.56

\(\pm\) 10.89

23.72

\(\pm\) 16.66

PTVlymph (12 Gy)

Plan

12.65 ± 0.16

14.36 ± 0.65

11.92 ± 0.23

12.22 ± 0.10

99.68 ± 0.24

99.53 ± 0.35

99.30 ± 0.51

98.93 ± 0.73

98.20 ± 1.09

94.68

\(\pm\) 1.97

Re-calculated

12.50 ± 0.19

14.38 ± 0.66

11.10 ± 1.24

11.96 ± 0.27

99.14 ± 1.06

98.73 ± 1.55

98.31 ± 1.72

97.65 ± 1.89

96.26 ± 2.24

90.07

\(\pm\) 5.13